Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 345

1.

Stroke Survivors' Perspectives on Post-Acute Rehabilitation Options, Goals, Satisfaction, and Transition to Home.

Krishnan S, Hay CC, Pappadis MR, Deutsch A, Reistetter TA.

J Neurol Phys Ther. 2019 Jul;43(3):160-167. doi: 10.1097/NPT.0000000000000281.

PMID:
31205230
2.

Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study.

Oldenburg J, Hay CRM, Jiménez-Yuste V, Peyvandi F, Schved JF, Szamosi J, Winding B, Lethagen S.

BMJ Open. 2019 May 30;9(5):e028012. doi: 10.1136/bmjopen-2018-028012.

3.

Staphylococcus lentus Sinusitis: A New Sinonasal Pathogen.

Hay CY, Sherris DA.

Ear Nose Throat J. 2019 May 9:145561319848990. doi: 10.1177/0145561319848990. [Epub ahead of print]

PMID:
31072191
4.

Varanid Lizard Venoms Disrupt the Clotting Ability of Human Fibrinogen through Destructive Cleavage.

Dobson JS, Zdenek CN, Hay C, Violette A, Fourmy R, Cochran C, Fry BG.

Toxins (Basel). 2019 May 7;11(5). pii: E255. doi: 10.3390/toxins11050255.

5.

Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.

Volkers P, Hanschmann KM, Calvez T, Chambost H, Collins PW, Demiguel V, Hart DP, Hay CRM, Goudemand J, Ljung R, Palmer BP, Santagostino E, van Hardeveld EM, van den Berg M, Keller-Stanislawski B.

Haemophilia. 2019 May;25(3):398-407. doi: 10.1111/hae.13747. Epub 2019 May 7.

PMID:
31066174
6.

Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom.

Zdenek CN, Hay C, Arbuckle K, Jackson TNW, Bos MHA, Op den Brouw B, Debono J, Allen L, Dunstan N, Morley T, Herrera M, Gutiérrez JM, Williams DJ, Fry BG.

Toxicol In Vitro. 2019 Aug;58:97-109. doi: 10.1016/j.tiv.2019.03.031. Epub 2019 Mar 22.

PMID:
30910521
7.

Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors.

Mansuet-Lupo A, Barritault M, Alifano M, Janet-Vendroux A, Zarmaev M, Biton J, Velut Y, Le Hay C, Cremer I, Régnard JF, Fournel L, Rance B, Wislez M, Laurent-Puig P, Herbst R, Damotte D, Blons H.

J Thorac Oncol. 2019 May;14(5):844-856. doi: 10.1016/j.jtho.2019.01.017. Epub 2019 Feb 2.

PMID:
30721797
8.

Expecting the unexpected: Acquired haemophilia A in a patient with homozygous factor V deficiency.

Denny N, Scott M, Hay C, Thachil J.

Haemophilia. 2019 Mar;25(2):e101-e103. doi: 10.1111/hae.13669. Epub 2019 Jan 28. No abstract available.

PMID:
30690823
9.

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study.

Hershberger E, Sloan S, Narayan K, Hay CA, Smith P, Engler F, Jeeninga R, Smits S, Trevejo J, Shriver Z, Oldach D.

EBioMedicine. 2019 Feb;40:574-582. doi: 10.1016/j.ebiom.2018.12.051. Epub 2019 Jan 9.

10.

Origin of spatial variation in US East Coast sea-level trends during 1900-2017.

Piecuch CG, Huybers P, Hay CC, Kemp AC, Little CM, Mitrovica JX, Ponte RM, Tingley MP.

Nature. 2018 Dec;564(7736):400-404. doi: 10.1038/s41586-018-0787-6. Epub 2018 Dec 19.

PMID:
30568196
11.

Chemotherapy in older adult gynecologic oncology patients: Can a phenotypic frailty score predict tolerance?

Hay CM, Donovan HS, Campbell GB, Taylor SE, Wang L, Courtney-Brooks M.

Gynecol Oncol. 2019 Feb;152(2):304-309. doi: 10.1016/j.ygyno.2018.11.031. Epub 2018 Nov 28.

PMID:
30503049
12.

Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study.

Scott MJ, Xiang H, Hart DP, Palmer B, Collins PW, Stephensen D, Sima CS, Hay CRM.

Haemophilia. 2019 Mar;25(2):205-212. doi: 10.1111/hae.13616. Epub 2018 Nov 8.

PMID:
30408835
13.

Lived experiences of chronic cognitive and mood symptoms among community-dwelling adults following stroke: a mixed-methods analysis.

Pappadis MR, Krishnan S, Hay CC, Jones B, Sander AM, Weller SC, Reistetter TA.

Aging Ment Health. 2018 Oct 27:1-7. doi: 10.1080/13607863.2018.1481927. [Epub ahead of print]

PMID:
30369243
14.

Sexual Health as Part of Gynecologic Cancer Care: What Do Patients Want?

Hay CM, Donovan HS, Hartnett EG, Carter J, Roberge MC, Campbell GB, Zuchelkowski BE, Taylor SE.

Int J Gynecol Cancer. 2018 Nov;28(9):1737-1742. doi: 10.1097/IGC.0000000000001376.

PMID:
30358703
15.

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.

Elizaga ML, Li SS, Kochar NK, Wilson GJ, Allen MA, Tieu HVN, Frank I, Sobieszczyk ME, Cohen KW, Sanchez B, Latham TE, Clarke DK, Egan MA, Eldridge JH, Hannaman D, Xu R, Ota-Setlik A, McElrath MJ, Hay CM; NIAID HIV Vaccine Trials Network (HVTN) 087 Study Team.

PLoS One. 2018 Sep 20;13(9):e0202753. doi: 10.1371/journal.pone.0202753. eCollection 2018.

16.

Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.

Gruppo RA, Malan D, Kapocsi J, Nemes L, Hay CRM, Boggio L, Chowdary P, Tagariello G, von Drygalski A, Hua F, Scaramozza M, Arkin S; Marzeptacog alfa (activated) Study Group Investigators.

J Thromb Haemost. 2018 Oct;16(10):1984-1993. doi: 10.1111/jth.14247. Epub 2018 Aug 27.

PMID:
30151972
17.

Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee.

Collins PW, Liesner R, Makris M, Talks K, Chowdary P, Chalmers E, Hall G, Riddell A, Percy CL, Hay CR, Hart DP.

Haemophilia. 2018 May;24(3):344-347. doi: 10.1111/hae.13495.

PMID:
30070072
18.

Support available for and perceived priorities of people with polymyalgia rheumatica and giant cell arteritis: results of the PMRGCAuk members' survey 2017.

Muller S, O'Brien A, Helliwell T, Hay CA, Gilbert K, Mallen CD, Busby K; PMRGCAuk.

Clin Rheumatol. 2018 Dec;37(12):3411-3418. doi: 10.1007/s10067-018-4220-1. Epub 2018 Jul 31.

PMID:
30066282
19.

The immunogenicity of ReFacto AF (moroctocog alfa AF-CC) in previously untreated patients with haemophilia A in the United Kingdom.

Mathias MC, Collins PW, Palmer BP, Chalmers E, Alamelu J, Richards M, Will A, Hay CRM; United Kingdom Haemophilia Centre Doctors’ Organisation Inhibitor Working Party.

Haemophilia. 2018 Nov;24(6):896-901. doi: 10.1111/hae.13551. Epub 2018 Jul 13.

PMID:
30004617
20.

Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies.

Evans PL, Prior JA, Belcher J, Mallen CD, Hay CA, Roddy E.

Arthritis Res Ther. 2018 Jul 5;20(1):136. doi: 10.1186/s13075-018-1612-1.

21.

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.

Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, Richman LP, Lin JH, Sun YH, Rech AJ, Balli D, Hay CA, Sela Y, Merrell AJ, Liudahl SM, Gordon N, Norgard RJ, Yuan S, Yu S, Chao T, Ye S, Eisinger-Mathason TSK, Faryabi RB, Tobias JW, Lowe SW, Coussens LM, Wherry EJ, Vonderheide RH, Stanger BZ.

Immunity. 2018 Jul 17;49(1):178-193.e7. doi: 10.1016/j.immuni.2018.06.006. Epub 2018 Jun 26.

PMID:
29958801
22.

Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.

Hay CE, Gonzalez GA 3rd, Ewing LE, Reichard EE, Hambuchen MD, Nanaware-Kharade N, Alam S, Bolden CT, Owens SM, Margaritis P, Peterson EC.

PLoS One. 2018 Jun 29;13(6):e0200060. doi: 10.1371/journal.pone.0200060. eCollection 2018.

23.

Minimal East Antarctic Ice Sheet retreat onto land during the past eight million years.

Shakun JD, Corbett LB, Bierman PR, Underwood K, Rizzo DM, Zimmerman SR, Caffee MW, Naish T, Golledge NR, Hay CC.

Nature. 2018 Jun;558(7709):284-287. doi: 10.1038/s41586-018-0155-6. Epub 2018 Jun 13.

PMID:
29899483
24.

Feasibility Study Using Propensity Score Matching Methods for the Pseudo-Common Person Equating Requirement.

Hong I, Hay CC, Reistetter TA.

OTJR (Thorofare N J). 2019 Jan;39(1):32-40. doi: 10.1177/1539449218778535. Epub 2018 Jun 8.

PMID:
29882470
25.

Super-Utilization of Health Care Resources Among Gynecologic Oncology Patients.

Hay CM, Kelley JL 3rd, Edwards RP, Pombier KM, Comerci JT Jr.

Am J Med Qual. 2018 Sep/Oct;33(5):509-513. doi: 10.1177/1062860618757343. Epub 2018 Feb 20.

PMID:
29463092
26.

Proteomic and functional variation within black snake venoms (Elapidae: Pseudechis).

Goldenberg J, Cipriani V, Jackson TNW, Arbuckle K, Debono J, Dashevsky D, Panagides N, Ikonomopoulou MP, Koludarov I, Li B, Santana RC, Nouwens A, Jones A, Hay C, Dunstan N, Allen L, Bush B, Miles JJ, Ge L, Kwok HF, Fry BG.

Comp Biochem Physiol C Toxicol Pharmacol. 2018 Feb;205:53-61. doi: 10.1016/j.cbpc.2018.01.001. Epub 2018 Jan 17.

PMID:
29353015
27.

A light-assisted in situ embedment of silver nanoparticles to prepare functionalized fabrics.

Toh HS, Faure RL, Mohd Amin LB, Hay CYF, George S.

Nanotechnol Sci Appl. 2017 Nov 30;10:147-162. doi: 10.2147/NSA.S139484. eCollection 2017.

28.

Evaluation of industrial by-products and natural minerals for phosphate adsorption from subsurface drainage.

Sellner BM, Hua G, Ahiablame LM, Trooien TP, Hay CH, Kjaersgaard J.

Environ Technol. 2019 Feb;40(6):756-767. doi: 10.1080/09593330.2017.1407364. Epub 2017 Dec 4.

PMID:
29157153
29.

Efficacy and safety of Nuwiq® (human-cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures.

Zozulya N, Kessler CM, Klukowska A, von Depka M, Hampton K, Hay CRM, Jansen M, Bichler J, Knaub S, Rangarajan S.

Haemophilia. 2018 Jan;24(1):70-76. doi: 10.1111/hae.13351. Epub 2017 Oct 19.

PMID:
29048712
30.

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.

Li SS, Kochar NK, Elizaga M, Hay CM, Wilson GJ, Cohen KW, De Rosa SC, Xu R, Ota-Setlik A, Morris D, Finak G, Allen M, Tieu HV, Frank I, Sobieszczyk ME, Hannaman D, Gottardo R, Gilbert PB, Tomaras GD, Corey L, Clarke DK, Egan MA, Eldridge JH, McElrath MJ, Frahm N; NIAID HIV Vaccine Trials Network.

Clin Vaccine Immunol. 2017 Nov 6;24(11). pii: e00263-17. doi: 10.1128/CVI.00263-17. Print 2017 Nov.

31.

Mechanical prosthetic heart valves (MPHV) in pregnancy are associated with a high risk of maternal and fetal morbidity and mortality.

Vause S, Clarke B, Tower C, Hay C, Knight M.

Heart. 2017 Oct;103(19):1557. doi: 10.1136/heartjnl-2017-311762. No abstract available.

PMID:
28894012
32.

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients.

Collins PW, Quon DVK, Makris M, Chowdary P, Kempton CL, Apte SJ, Ramanan MV, Hay CRM, Drobic B, Hua Y, Babinchak TJ, Gomperts ED.

Haemophilia. 2018 Jan;24(1):104-112. doi: 10.1111/hae.13324. Epub 2017 Aug 17.

33.

Sub-Galeal Pneumocele 20 Years after Cochlear Implantation.

Hay C, Sharma N, Gadre A.

J Int Adv Otol. 2017 Aug;13(2):279-281. doi: 10.5152/iao.2017.4067.

34.

The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation.

Hay CRM, Xiang H, Scott M, Collins PW, Liesner R, Dolan G, Hollingsworth R.

Haemophilia. 2017 Sep;23(5):728-735. doi: 10.1111/hae.13287. Epub 2017 Aug 14.

PMID:
28806858
35.

Tissue control of androgen action: The ups and downs of androgen receptor expression.

Hunter I, Hay CW, Esswein B, Watt K, McEwan IJ.

Mol Cell Endocrinol. 2018 Apr 15;465:27-35. doi: 10.1016/j.mce.2017.08.002. Epub 2017 Aug 5. Review.

PMID:
28789969
36.

Strategies for Introducing Outpatient Specialty Palliative Care in Gynecologic Oncology.

Hay CM, Lefkowits C, Crowley-Matoka M, Bakitas MA, Clark LH, Duska LR, Urban RR, Creasy SL, Schenker Y.

J Oncol Pract. 2017 Sep;13(9):e712-e720. doi: 10.1200/JOP.2017.020818. Epub 2017 Aug 1.

37.

Catch a tiger snake by its tail: Differential toxicity, co-factor dependence and antivenom efficacy in a procoagulant clade of Australian venomous snakes.

Lister C, Arbuckle K, Jackson TNW, Debono J, Zdenek CN, Dashevsky D, Dunstan N, Allen L, Hay C, Bush B, Gillett A, Fry BG.

Comp Biochem Physiol C Toxicol Pharmacol. 2017 Nov;202:39-54. doi: 10.1016/j.cbpc.2017.07.005. Epub 2017 Jul 27.

PMID:
28757215
38.

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.

Buchbinder SP, Grunenberg NA, Sanchez BJ, Seaton KE, Ferrari G, Moody MA, Frahm N, Montefiori DC, Hay CM, Goepfert PA, Baden LR, Robinson HL, Yu X, Gilbert PB, McElrath MJ, Huang Y, Tomaras GD; HIV Vaccine Trials Network (HVTN) 094 Study Group.

PLoS One. 2017 Jul 20;12(7):e0179597. doi: 10.1371/journal.pone.0179597. eCollection 2017.

39.

Management of pregnancy in type 3 von Willebrand disease with alloantibodies.

Scott M, Hay CRM, Elkhalifa S, Tower C, Cocker M, Thachil J.

Br J Haematol. 2018 Aug;182(3):440-442. doi: 10.1111/bjh.14805. Epub 2017 Jul 12. No abstract available.

PMID:
28699647
40.

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy.

Pasi KJ, Rangarajan S, Georgiev P, Mant T, Creagh MD, Lissitchkov T, Bevan D, Austin S, Hay CR, Hegemann I, Kazmi R, Chowdary P, Gercheva-Kyuchukova L, Mamonov V, Timofeeva M, Soh CH, Garg P, Vaishnaw A, Akinc A, Sørensen B, Ragni MV.

N Engl J Med. 2017 Aug 31;377(9):819-828. doi: 10.1056/NEJMoa1616569. Epub 2017 Jul 10.

41.

Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases.

Vijayan D, Barkauskas DS, Stannard K, Sult E, Buonpane R, Takeda K, Teng MWL, Sachsenmeier K, Hay C, Smyth MJ.

Oncoimmunology. 2017 Apr 5;6(5):e1312044. doi: 10.1080/2162402X.2017.1312044. eCollection 2017.

42.

Management of parturients with Factor XI deficiency-10year case series and review of literature.

Verghese L, Tingi E, Thachil J, Hay C, Byrd L.

Eur J Obstet Gynecol Reprod Biol. 2017 Aug;215:85-92. doi: 10.1016/j.ejogrb.2017.06.008. Epub 2017 Jun 6. Review.

PMID:
28622635
43.

First-line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working Parties.

Collins P, Chalmers E, Alamelu J, Hay C, Liesner R, Makris M, Mathias M, Payne J, Rangarajan S, Richards M, Talks K, Tunstall O, Williams M, Hart DP.

Haemophilia. 2017 Sep;23(5):654-659. doi: 10.1111/hae.13264. Epub 2017 Jun 2. No abstract available.

PMID:
28574205
44.

Application of the Korean Version of the Modified Barthel Index: Development of a keyform for use in Clinical Practice.

Hong I, Lim Y, Han H, Hay CC, Woo HS.

Hong Kong J Occup Ther. 2017 Jun;29(1):39-46. doi: 10.1016/j.hkjot.2017.06.001. Epub 2017 Jul 6.

45.

Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and Finland.

Scott M, Nummi V, Lassila R, Xiang H, Hay CRM.

Haemophilia. 2017 May;23(3):e240-e243. doi: 10.1111/hae.13228. No abstract available.

PMID:
28520204
46.

Correlation between ontogenetic dietary shifts and venom variation in Australian brown snakes (Pseudonaja).

Cipriani V, Debono J, Goldenberg J, Jackson TNW, Arbuckle K, Dobson J, Koludarov I, Li B, Hay C, Dunstan N, Allen L, Hendrikx I, Kwok HF, Fry BG.

Comp Biochem Physiol C Toxicol Pharmacol. 2017 Jul;197:53-60. doi: 10.1016/j.cbpc.2017.04.007. Epub 2017 Apr 27.

PMID:
28457945
47.

Stopping conventional showering decreases Pseudomonas infections in left ventricular assist device patients.

Aburjania N, Sherazi S, Tchantchaleishvili V, Alexis JD, Hay CM.

Int J Artif Organs. 2017 Jun 9;40(6):282-285. doi: 10.5301/ijao.5000590. Epub 2017 Apr 18.

PMID:
28430297
48.

Patient-centered mobility outcome preferences according to individuals with stroke and caregivers: a qualitative analysis.

Krishnan S, Pappadis MR, Weller SC, Fisher SR, Hay CC, Reistetter TA.

Disabil Rehabil. 2018 Jun;40(12):1401-1409. doi: 10.1080/09638288.2017.1297855. Epub 2017 Mar 21.

49.

Prothrombin complex concentrate to correct acquired abnormalities of the clotting screen in patients with liver impairment.

Scott M, Ramsay R, Hay CRM, Thachil J.

Liver Int. 2017 Aug;37(8):1249-1250. doi: 10.1111/liv.13398. Epub 2017 Mar 17. No abstract available.

PMID:
28241398
50.

Individual and combined effects of Aflatoxin B1, Deoxynivalenol and Zearalenone on HepG2 and RAW 264.7 cell lines.

Zhou H, George S, Hay C, Lee J, Qian H, Sun X.

Food Chem Toxicol. 2017 May;103:18-27. doi: 10.1016/j.fct.2017.02.017. Epub 2017 Feb 20.

PMID:
28223122

Supplemental Content

Support Center